Identification of the NRF2 transcriptional network as a therapeutic target for trigeminal neuropathic pain

Trigeminal neuralgia, historically dubbed the “suicide disease,” is an exceedingly painful neurologic condition characterized by sudden episodes of intense facial pain. Unfortunately, the only U.S. Food and Drug Administration (FDA)–approved medication for trigeminal neuralgia carries substantial si...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasavda, Chirag, Xu, Risheng, Liew, Jason, Kothari, Ruchita, Dhindsa, Ryan S., Semenza, Evan R., Paul, Bindu D., Green, Dustin P., Sabbagh, Mark F., Shin, Joseph Y., Yang, Wuyang, Snowman, Adele M., Albacarys, Lauren K., Moghekar, Abhay, Pardo-Villamizar, Carlos A., Luciano, Mark, Huang, Judy, Bettegowda, Chetan, Kwatra, Shawn G., Dong, Xinzhong, Lim, Michael, Snyder, Solomon H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348805/
https://www.ncbi.nlm.nih.gov/pubmed/35921423
http://dx.doi.org/10.1126/sciadv.abo5633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348805/
https://www.ncbi.nlm.nih.gov/pubmed/35921423
http://dx.doi.org/10.1126/sciadv.abo5633

Ejemplares similares